These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

718 related articles for article (PubMed ID: 22191795)

  • 1. Contributions of brain insulin resistance and deficiency in amyloid-related neurodegeneration in Alzheimer's disease.
    de la Monte SM
    Drugs; 2012 Jan; 72(1):49-66. PubMed ID: 22191795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain insulin resistance and deficiency as therapeutic targets in Alzheimer's disease.
    de la Monte SM
    Curr Alzheimer Res; 2012 Jan; 9(1):35-66. PubMed ID: 22329651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain metabolic dysfunction at the core of Alzheimer's disease.
    de la Monte SM; Tong M
    Biochem Pharmacol; 2014 Apr; 88(4):548-59. PubMed ID: 24380887
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insulin and insulin-like growth factor expression and function deteriorate with progression of Alzheimer's disease: link to brain reductions in acetylcholine.
    Rivera EJ; Goldin A; Fulmer N; Tavares R; Wands JR; de la Monte SM
    J Alzheimers Dis; 2005 Dec; 8(3):247-68. PubMed ID: 16340083
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ACH2.0/E, the Consolidated Theory of Conventional and Unconventional Alzheimer's Disease: Origins, Progression, and Therapeutic Strategies.
    Volloch V; Rits-Volloch S
    Int J Mol Sci; 2024 May; 25(11):. PubMed ID: 38892224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Next Generation Therapeutic Strategy for Treatment and Prevention of Alzheimer's Disease and Aging-Associated Cognitive Decline: Transient, Once-in-a-Lifetime-Only Depletion of Intraneuronal Aβ (
    Volloch V; Rits-Volloch S
    Int J Mol Sci; 2023 Dec; 24(24):. PubMed ID: 38139415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conquering Insulin Network Dysfunctions in Alzheimer's Disease: Where Are We Today?
    de la Monte SM
    J Alzheimers Dis; 2024; 101(s1):S317-S343. PubMed ID: 39422949
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Amyloid Cascade Hypothesis 2.0 for Alzheimer's Disease and Aging-Associated Cognitive Decline: From Molecular Basis to Effective Therapy.
    Volloch V; Rits-Volloch S
    Int J Mol Sci; 2023 Jul; 24(15):. PubMed ID: 37569624
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Alzheimer's disease.
    De-Paula VJ; Radanovic M; Diniz BS; Forlenza OV
    Subcell Biochem; 2012; 65():329-52. PubMed ID: 23225010
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of neuronal insulin/insulin-like growth factor-1 signaling for the pathogenesis of Alzheimer's disease: possible therapeutic implications.
    Zemva J; Schubert M
    CNS Neurol Disord Drug Targets; 2014 Mar; 13(2):322-37. PubMed ID: 24059318
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential effects of diet- and genetically-induced brain insulin resistance on amyloid pathology in a mouse model of Alzheimer's disease.
    Wakabayashi T; Yamaguchi K; Matsui K; Sano T; Kubota T; Hashimoto T; Mano A; Yamada K; Matsuo Y; Kubota N; Kadowaki T; Iwatsubo T
    Mol Neurodegener; 2019 Apr; 14(1):15. PubMed ID: 30975165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Decoding Alzheimer's disease from perturbed cerebral glucose metabolism: implications for diagnostic and therapeutic strategies.
    Chen Z; Zhong C
    Prog Neurobiol; 2013 Sep; 108():21-43. PubMed ID: 23850509
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondria-targeted catalase reduces abnormal APP processing, amyloid β production and BACE1 in a mouse model of Alzheimer's disease: implications for neuroprotection and lifespan extension.
    Mao P; Manczak M; Calkins MJ; Truong Q; Reddy TP; Reddy AP; Shirendeb U; Lo HH; Rabinovitch PS; Reddy PH
    Hum Mol Genet; 2012 Jul; 21(13):2973-90. PubMed ID: 22492996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. O-GlcNAcylation of Amyloid-β Protein Precursor by Insulin Signaling Reduces Amyloid-β Production.
    Kwon OH; Cho YY; Kim TW; Chung S
    J Alzheimers Dis; 2019; 69(4):1195-1211. PubMed ID: 31156159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Insulin resistance and Alzheimer's disease.
    de la Monte SM
    BMB Rep; 2009 Aug; 42(8):475-81. PubMed ID: 19712582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mapping pathogenic processes contributing to neurodegeneration in Drosophila models of Alzheimer's disease.
    Bergkvist L; Du Z; Elovsson G; Appelqvist H; Itzhaki LS; Kumita JR; Kågedal K; Brorsson AC
    FEBS Open Bio; 2020 Mar; 10(3):338-350. PubMed ID: 31823504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Functional roles of amyloid-beta protein precursor and amyloid-beta peptides: evidence from experimental studies.
    Hiltunen M; van Groen T; Jolkkonen J
    J Alzheimers Dis; 2009; 18(2):401-12. PubMed ID: 19584429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic adiponectin deficiency leads to Alzheimer's disease-like cognitive impairments and pathologies through AMPK inactivation and cerebral insulin resistance in aged mice.
    Ng RC; Cheng OY; Jian M; Kwan JS; Ho PW; Cheng KK; Yeung PK; Zhou LL; Hoo RL; Chung SK; Xu A; Lam KS; Chan KH
    Mol Neurodegener; 2016 Nov; 11(1):71. PubMed ID: 27884163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dysfunctional pro-ceramide, ER stress, and insulin/IGF signaling networks with progression of Alzheimer's disease.
    de la Monte SM; Re E; Longato L; Tong M
    J Alzheimers Dis; 2012; 30 Suppl 2(0 2):S217-29. PubMed ID: 22297646
    [TBL] [Abstract][Full Text] [Related]  

  • 20. On the Inadequacy of the Current Transgenic Animal Models of Alzheimer's Disease: The Path Forward.
    Volloch V; Rits-Volloch S
    Int J Mol Sci; 2024 Mar; 25(5):. PubMed ID: 38474228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.